who discovered glp 1 agonists A Brief History of GLP-1 Agonists: From Discovery to Modern The expanding landscape of GLP-1

This is a superior advantage of GLP-1R pharmaceuticals as many other drugs used to treat T2DM are weight neutral or actual cause weight gain

& Basu, A

Changes from baseline in cardiovascular, metabolic, and inflammatory biomarkers among GLP-1 drug users were as follows: Triglycerides: -16.4 mg/dL LDL cholesterol: -7.3 mg/dL HbA1c: -0.3 percentage points CRP: -0.6 mg/dL ESR: -3.0 mm/hr These were all numerically greater than corresponding changes for non-users, but often the differences didn't reach statistical significance

Archived from the original on 4 January 2024

Impact of GLP-1 agonists on Male reproductive Health-A narrative review